Question
Classify antifungal drugs. Explain the mechanism of action, uses, and adverse effects of Amphotericin B.
Add a note on the various liposomal formulations of Amphotericin B
(2+6+2)
Answer
Classification of antifungal drugs
| Class | Examples |
|---|---|
| Polyenes | Amphotericin B, Nystatin |
| Azoles | Fluconazole, Itraconazole, Ketoconazole |
| Echinocandins | Caspofungin, Micafungin |
| Others | Flucytosine, Terbinafine, Griseofulvin |
Amphotericin B — mechanism, uses, adverse effects Mechanism: binds ergosterol directly in the fungal cell membrane, forming pores that disrupt membrane integrity and cause leakage of intracellular contents — fungicidal. Selectivity depends on ergosterol-versus-cholesterol binding preference, real but imperfect (residual cholesterol affinity, particularly renal tubular cells).
Uses: severe systemic/invasive fungal infections (invasive candidiasis, aspergillosis, cryptococcal meningitis), visceral leishmaniasis.
Adverse effects: nephrotoxicity (dose-limiting), infusion-related reactions (fever, chills, rigors), hypokalemia, hypomagnesemia, anemia.
Note on liposomal formulations Lipid-based formulations (liposomal amphotericin B, amphotericin B lipid complex, amphotericin B colloidal dispersion) encapsulate the drug in a lipid carrier, substantially reducing off-target renal tubular binding while preserving — and in visceral leishmaniasis, actually improving via preferential reticuloendothelial uptake — antifungal efficacy. This favorable safety profile allows higher doses and shorter treatment courses, at significantly higher cost than conventional amphotericin B.

